Interferon-Beta for Glomerulonephritis?

被引：0

作者：

Wardle, E. Nigel

机构：

来源：

SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION | 2007年 / 18卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Interferon beta (IFN) is used in the therapy of multiple sclerosis (MS), which develops from the activation of autoreactive T lymphocytes against peptides of myelin basic protein. IFN was demonstrated to have beneficial effects in experimental models of glomerulonephritis (GN), such as decreasing proteinuria via Il-10 release. T helper (Th-1) lymphocyte responses are reduced, the actions of metalloproteinase (MMP9) are suppressed, and the functions of regulatory T cells are promoted. In concept, IFNI3 therapy might be beneficial in patients with life threatening forms of GN, such as Goodpastures syndrome or vasculitis. Further research is warranted to study the effect of IFN on GN in clinical settings.

引用

收藏

页码：333 / 336

页数：4

相关论文

共 22 条

[11] Systemic lupus erythematosus: all roads lead to type I interferons [J].

Pascual, Virginia ;

Farkas, Lorant ;

Banchereau, Jacques .

CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (06) :676-682

[12] TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus [J].

Roennefarth, Viktoria M. ;

Erbacher, Annika I. M. ;

Lamkemeyer, Tobias ;

Madlung, Johannes ;

Nordheim, Alfred ;

Rammensee, Hans-Georg ;

Decker, Patrice .

JOURNAL OF IMMUNOLOGY, 2006, 177 (11) :7740-7749

[13] Defining the mechanism by which IFN-β dowregulates c-myc expression in human melanoma cells:: pivotal role for human polynucleotide phosphorylase (hPNPaseold-35) [J].

Sarkar, D. ;

Park, E. S. ;

Fisher, P. B. .

CELL DEATH AND DIFFERENTIATION, 2006, 13 (09) :1541-1553

[14]

Satchell S C, INTERFERON IN PRESS

[15]

Scheel-Toellner D, 2002, EUR J IMMUNOL, V32, P486, DOI 10.1002/1521-4141(200202)32:2<486::AID-IMMU486>3.0.CO

[16]

2-U

[17] Interferon-β:: A therapeutic for autoimmune lupus in MRL-Faslpr mice [J].

Schwarting, A ;

Paul, K ;

Tschirner, S ;

Menke, J ;

Hansen, T ;

Brenner, W ;

Kelley, VR ;

Relle, M ;

Galle, PR .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11) :3264-3272

[18] TLR signaling pathways [J].

Takeda, K ;

Akira, S .

SEMINARS IN IMMUNOLOGY, 2004, 16 (01) :3-9

[19]

Teige I, 2006, J IMMUNOL, V177, P3554

[20] Contribution of interferon-β to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide [J].

Thomas, Karen E. ;

Galligan, Carole L. ;

Newman, Raj Deonarain ;

Fish, Eleanor N. ;

Vogel, Stefanie N. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (41) :31119-31130